Viral Vector Vaccines

COVID-19 Vaccines: Viral Vector Vaccines

Janssen COVID-19 Vaccine Booster Dose (November 3, 2021)
This course will review the clinical evidence and safety data as well as additional information on Thrombosis with Thrombocytopenia Syndrome (TTS) and Guillain-Barre Syndrome (GBS). (APhA Education During COVID-19 – CPE)
Janssen COVID-19 Vaccine (J&J) Overview—What Pharmacists Need to Know (March 18, 2021)
Join us for an overview of the Janssen (J&J) COVID-19 vaccine as we review the mechanism of action, efficacy and safety data, storage and handling information, and vaccine hesitancy data. This one-stop program will cover everything you need to know about the vaccine. (APhA 15 on COVID-19 - CPE Video)
Adenovirus Vector Technology (March 3, 2021)
We examine how adenovirus-based vaccines work, answer some of the common questions that patients may be asking, and look at the history of adenovirus-based vaccines. (APhA 15 on COVID-19 - CPE Video)
CDC’s Janssen (J&J) COVID-19 Vaccine provides administration and storage information as well as clinical considerations.
FDA's Janssen (J&J) COVID-19 Vaccine EUA Fact Sheet for Healthcare Providers and for Recipients and Caregivers.
CDC issued a health alert (April 13) regarding cases of a rare type of blood clot in individuals after receiving the Janssen (J&J) COVID-19 vaccine. The alert includes recommendations for clinicians.